Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Nihtinen, A
Volin, L
Juvonen, E
Ruutu, T
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [21] Treosulfan/fludarabine - a low toxicity but myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
    Holowiecki, J
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Kruzel, T
    Markiewicz, M
    BLOOD, 2004, 104 (11) : 292A - 292A
  • [22] Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia
    Mohammad Faizan Zahid
    Natasha Ali
    Medical Oncology, 2015, 32
  • [23] Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia
    Zahid, Mohammad Faizan
    Ali, Natasha
    MEDICAL ONCOLOGY, 2015, 32 (07)
  • [24] Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
    Lekakis, Lazaros
    de Lima, Marcos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 785 - 798
  • [25] Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation A Clinical Review
    Pollack, Seth M.
    O'Connor, Thomas P., Jr.
    Hashash, Jana
    Tabbara, Imad A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (06): : 618 - 628
  • [26] Conditioning with treosulfan and fludarabine for allogeneic blood stem cell transplantation
    Casper, J
    Steiner, B
    Wolff, D
    Kleine, HD
    Wilhelm, S
    Hammer, U
    von Wurmb, N
    Roeber, S
    Wegener, R
    Freund, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S285 - S286
  • [27] Transplantation tolerance in allogeneic stem cell transplantation with reduced-intensity conditioning
    Laylor, R
    Dyson, P
    Dewchand, H
    Simpson, E
    Dazzi, F
    BONE MARROW TRANSPLANTATION, 2004, 33 : S74 - S75
  • [28] Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
    Kekre, Natasha
    Marquez-Malaver, Francisco J.
    Cabrero, Monica
    Pinana, Jl
    Esquirol, Albert
    Soiffer, Robert J.
    Caballero, Dolores
    Terol, M. J.
    Martino, Rodrigo
    Antin, Joseph H.
    Lopez-Corral, L.
    Solano, Carlos
    Armand, Philippe
    Perez-Simon, Jose A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1808 - 1815
  • [29] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    Nakamura, R.
    Rodriguez, R.
    Palmer, J.
    Stein, A.
    Naing, A.
    Tsai, N.
    Chang, K.
    Slovak, M. L.
    Bhatia, R.
    Spielberger, R.
    Kogut, N.
    Pullarkat, V.
    Kirschbaum, M.
    Forman, S. J.
    O'Donnell, M. R.
    BONE MARROW TRANSPLANTATION, 2007, 40 (09) : 843 - 850
  • [30] COMBINATION OF FLUDARABINE, AMSACRINE AND CYTARABINE FOLLOWED BY REDUCED-INTENSITY CONDITIONING AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 15 PATIENTS WITH MYELOFIBROSIS
    Krejci, M.
    Doubek, M.
    Brychtova, Y.
    Tomiska, M.
    Horky, O.
    Sandecka, V.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S193 - S194
12345